Concepedia

Phillip M. Cowley

PM

Statistics

Publications

12

Citations

721

H-Index

12

Active since

1993

Affiliations

NHS Lanarkshire(Current)

University of Manchester

Merck & Co., Inc., Rahway, NJ, USA (United States)

Phillip M. Cowley is an author at NHS Lanarkshire specializing in medicinal chemistry, pharmacology, and pharmacy.

Publications per year

1993–2020

12

Publications

12

Allosteric Modulation of the Cannabinoid CB1 Receptor

M. R. Price, Gemma L. Baillie, Adèle Thomas et al. · Molecular Pharmacology · 2005 · 447 citations

, , +17

Asymmetric synthesis of (3S)-2,3,4,5-tetrahydropyridazine-3-carboxylic acid

Ian H. Aspinall, Phillip M. Cowley, Glynn Mitchell et al. · Journal of the Chemical Society Chemical Communications · 1993 · 50 citations

, , +6

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Julia M. Adam, Jim Cairns, Wilson Caulfield et al. · MedChemComm · 2010 · 36 citations

, , +17

Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)

Catherine A. White, Meredeth A. McGowan, Hua Zhou et al. · ACS Medicinal Chemistry Letters · 2020 · 34 citations · Full text

, , +16

Asymmetric synthesis of (3S )-2,3,4,5-tetrahydropyridazine-3-carboxylic acid and its methyl ester †

Ian H. Aspinall, Phillip M. Cowley, Glynn Mitchell et al. · Journal of the Chemical Society Perkin Transactions 1 · 1999 · 29 citations

, , +12

1–5 of 12